Olgu Erkin Çınar

10PUBLICATIONS
50CO-AUTHORS
HaematologyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation.

|Jul 28, 2026
A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen.

|Dec 23, 2025
Risk Factors for Infectious Adverse Events in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Venetoclax Combinations: A Retrospective Single-Centre Real-World Experience.

Olgu Erkin Çınar, Azade Kanat, Kerim Erer

|Nov 11, 2022
Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874.

Olgu Erkin Çınar, Batuhan Erdoğdu, Mine Karadeniz

|Apr 21, 2022
Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

Olgu Erkin Çınar, Hakan Göker, Kemal Fidan

|Apr 21, 2021
The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients

Ayşe Karataş, Ümit Yavuz Malkan, Mustafa Velet

Pageof 2

Frequent Collaborators

4 joint publications

İbrahİm Celalettin Haznedaroğlu

3 joint publications

Ümit Yavuz Malkan

2 joint publications

Osman Özcebe

2 joint publications

Leylagül Kaynar